Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APD356 in obese patients
NCT00104507Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2004
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lorcaserin in obesity (4 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Change in body weight at 4 weeks. Started Dec 2004; status: completed.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00104507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104507.